| D-0412-2022 | Class II | MVASI, (bevacizumab-awwb), Sterile Ophthalmic Solution for Injection, 3.25mg/0.13mL (25 mg/mL) 0.13 | December 6, 2021 |
| D-0430-2022 | Class II | Cantharidin PLUS, Cantharidin/Salicylic Acid Gel-Forming Suspension, 10 mL per vial, Multiple Dose V | December 6, 2021 |
| D-0403-2022 | Class II | Gemcitabine, Sterile Intravesical Solution, Preservative Free, 1g/50mL (20 mg/mL), 50 mL per syringe | December 6, 2021 |
| D-0448-2022 | Class II | Vancomycin HCl Oral Solution (PF) 125mg / 2.5mL (50 mg/mL), 2.5 mL per syringe, Single Dose Syringe | December 6, 2021 |
| D-0419-2022 | Class II | Phenylephrine HCl/Lidocaine, Sterile Ophthalmic Solution for Injection, Preservative Free, 1.5%/1%, | December 6, 2021 |
| D-0405-2022 | Class II | Methacholine Challenge 5-Syringe Test Kit, Sterile Inhalation Solution, Preservative Free, 3 mL per | December 6, 2021 |
| D-0432-2022 | Class II | CSF-HC Otic Insufflation Capsule, Sulfacetamide Sodium/Ciprofloxacin/Hydrocortisone/Amphotericin B O | December 6, 2021 |
| D-0421-2022 | Class II | Phenylephrine HCl/Tropicamide/Cyclopentolate HCl/Ketorolac Sterile Ophthalmic Solution, 2.5%/0.25%/0 | December 6, 2021 |
| D-0429-2022 | Class II | Cantharidin Gel-Forming Suspension, 0.7%, 10 mL per vial, Multiple Dose Vial for Topical Use, Edge P | December 6, 2021 |
| D-0442-2022 | Class II | Profound-PE Dental Gel, Lidocaine HCl/Prilocaine HCl/Tetracaine HCl/Phenylephrine, 10% / 10% / 4% / | December 6, 2021 |
| D-0441-2022 | Class II | Profound-PE Dental Gel, Lidocaine HCl/ Prilocaine HCl/ Tetracaine HCl/ Phenylephrin HCl, 10% / 10% / | December 6, 2021 |
| D-0426-2022 | Class II | Vancomycin HCl in 0.9% Sodium Chloride Injection, 1,500 mg/500 mL, USP, Single Use Bag for IV Inject | December 6, 2021 |
| D-0413-2022 | Class II | Phenol, Sterile Solution for Injection (PF), 6%, 5 mL per vial, Single Use Vial for Perineural Injec | December 6, 2021 |
| D-0416-2022 | Class II | Phenylephrine HCl, 1mg/10mL (0.1mg/mL), 10 mL per syringe, Single Use Syringe for IV Injection, Edge | December 6, 2021 |
| D-0443-2022 | Class II | Phenol, Topical Solution (PF) Multiple Dose Vial, 89%, 3 mL per vial, Edge Pharma, LLC, 856 Hercules | December 6, 2021 |
| D-0440-2022 | Class II | Profound Dental Gel, Lidocaine HCl/Prilocaine HCl/Tetracaine HCl, 10% / 10% / 4%, Spearmint-Peppermi | December 6, 2021 |
| D-0399-2022 | Class II | Dexamethasone sodium phosphate, sterile otic solution for injection Preservative free, 19.2 mg/0.8mL | December 6, 2021 |
| D-0431-2022 | Class II | CSF Otic Insufflation Capsule, Sulfacetamide Sodium/ Ciprofloxacin/ Amphotericin B Otic Powder, 50mg | December 6, 2021 |
| D-0409-2022 | Class II | Mitomycin-C, Sterile Ophthalmic Solution, Preservative Free, 0.16mg/0.8mL (0.2 mg/mL), 0.8 mL per sy | December 6, 2021 |
| D-0423-2022 | Class II | Betadine (povidone-iodine), Sterile Ophthalmic Solution, Preservative Free, 5% 0.5mL per syringe, Si | December 6, 2021 |